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| INTRODUCTION
Homonymous hemianopia results in loss of one-half of the visual field in both eyes. 1, 2 The reported prevalence of visual field loss following stroke has been as high as 63% 3 in hospital populations although estimates vary widely as the proportion testing positive is highly dependent on time post-stroke. Visual field defects can seriously impact functional ability and quality of life following stroke. 4, 5 Patients with visual field defects have an increased risk of falling, 6 impaired ability to read, poor mood and institutionalization. [6] [7] [8] [9] Visual field loss may impact on a patient's ability to participate in rehabilitation and may ultimately result in poor long-term recovery. 8 Visual field loss can result in accidents or injuries which have subsequent cost implications to the NHS and the patient. The aim of this pilot trial was to compare visual rehabilitation interventions with NHS standard care, in patients with hemianopia following stroke. We wished to explore whether visual rehabilitation was more effective than standard care (advice only) at improving functional outcome in patients with hemianopia following stroke and whether prism therapy or visual search therapy was more effective at improving functional outcome in patients with hemianopia following stroke.
| METHODS

| Trial design
Visual Impairment after Stroke: Intervention Or Not (VISION) was a randomized controlled, multicentre pilot trial with NHS research ethical approval (10/H1003/119). The trial protocol is reported elsewhere. 
| Participants
Patients were eligible for inclusion if they met the following criteria:
a. 18 years of age or older;
b. Best corrected visual acuity of 0.5 or better in each eye at distance;
Randomization: Randomization block lists stratified by site and partial/complete hemianopia.
Blinding: Allocations disclosed to patients. Primary outcome assessor blind to treatment allocation.
Results: Eighty-seven patients were recruited: 27-Fresnel prisms, 30-visual search training and 30-standard care; 69% male; mean age 69 years (SD 12 
| Recruitment and randomization
Participants were individually randomized to one of three treatment groups using a secure (24-hour) web-based randomization programme.
Randomization lists were generated using block randomization stratified by centre and degree of hemianopia (partial or complete) with treatment allocation ratio of 1:1:1. The local PI (orthoptist) obtained the treatment allocation and subsequently assigned the participant to the treatment arm.
| Interventions
| Treatment A: Fresnel prisms
Participants were assessed and given sector Fresnel prisms of 40 prism dioptre strength on their glasses (or plain glasses if not already worn).
14 Separate prism segments were used as a mechanical displacement to expand the upper and lower quadrants. Full fitting details are detailed in the protocol. 13 Participants were advised to wear the prisms for a minimum of 2 hours daily, for a minimum 6 weeks, from prism affixation; after this, they could elect to continue treatment if wished.
| Treatment B: Visual search training
Participants were assessed and provided with visual search training.
This comprised an A4 landscape card with horizontal and diagonal numbered circles radiating out from a central fixation target. Full instructions for training are detailed in the protocol. Participants in all treatment groups received these information leaflets. Details of usage of the prisms and visual search training were collected by diaries, completed daily by participants.
| Outcomes
Outcomes were assessed at baseline and 6, 12 and 26 weeks. The assessed through questionnaire booklets. 13 Further key objectives of this pilot trial were to test the operationalization of the intervention and the study outcome measures.
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| Sample size calculation
A sample size calculation was estimated for repeated measures analysis of covariance, 16 using the data generated on visual field assessment.
| Visual field assessment
A blinded qualified orthoptist assessed visual field area. An Esterman strategy was used for quantitative visual field assessment with standard fixation monitoring strategies of fixation loss, false-positive and false-negative responses. This was done using either of the following:
• The Esterman programme on Humphrey or Octopus perimetry,
• The III4e target on Goldmann with additional checks of static points in the central visual field.
A template for Goldmann perimetry was supplied for standardization to match the Esterman strategy on Humphrey and Octopus perimetry. A binocular visual field was measured first followed by monocular assessment of the right and left eyes. Visual fields were performed without prisms in place in the Fresnel prisms arm. Where it was not possible to use either of these methods, then the standardized confrontation method was used. Whichever method used at baseline was repeated at every follow-up visit. Where the confrontation method was used at baseline, one of the above quantitative methods was used at the follow-up if possible in addition to repeating the confrontation method.
| Reading ability
Reading ability, assessed using the Radner reading test, is reported as time taken to read (seconds) and number of incorrect words from the 14 word passage. 
| Statistical analysis
There were insufficient data to carry out a formal power calculation to determine sample size for this trial; a sample size of 105 participants was considered sufficient to reach pilot objectives.
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Outcome data were analysed according to the intention-to-treat principle. Safety analyses included all patients who were randomized to and received treatment. A P-value of .05 is considered significant; however, as this is a pilot study not powered to identify differences, results will be interpreted with caution. Additionally, rather than adjust for multiplicity, relevant results from other studies will be taken into account in the interpretation of results.
The statistical analysis plan, written by the trial statisticians and agreed by other members of the trial management group (TMG) and independent oversight committees: data and safety monitoring committee (IDSMC) and the trial steering committee (TSC), prior to any comparative analyses together is available on request from the authors. No imputation methods were used for missing data, and all patients who withdrew from the trial were encouraged to complete follow-up.
All analyses were performed with SAS software version 9.2. The primary feasibility outcome of sample size calculation was calculated for a repeated measures analysis of covariance. 16 Data collected from the trial were used to estimate the standard deviation, estimate of correlation and the loss to follow-up rate for the main trial. All outcomes were summarized using descriptive statistics, split by treatment, at 
| Recruitment and characteristics
Recruitment and screening have been reported elsewhere 23 . In summary, 1171 patients were assessed for eligibility between 17
May 2011 and 9 September 2013. Of these, 993 patients (84.8%)
did not meet the inclusion criteria, 91 patients declined to participate (7.8%) leaving 87 patients in the study (7.4%). The reasons for not being eligible and for refusing to consent were recorded and published. 23 In May 2012, the team noted that the proportion of eligible patients was lower than expected and this was slowing recruitment.
Upon reviewing the accumulating recruitment data, the IDSMC rec- (Table 3 ).
| Sample size outcome
| Primary clinical outcome
There was some variability in baseline relative change in visual field area across treatment arm and by method ( respectively. These differences can be explained by the large withingroup variances of visual field expected with a relatively low sample size per method of assessment and per arm.
The mean values of relative change in visual field area are given
in Table 5 , which shows a non-significant average minimal increase in visual field at 26 weeks of 5%, 8% and 3.5% for Fresnel prisms, Visual search training and standard care, respectively (P-values >5%, <5% and >5%, respectively).
| Secondary clinical outcomes
Change in functional activity was evaluated as a secondary analysis. 
| Compliance
There were 73 protocol deviations in 58 patients (68.2% overall: 77% in the Fresnel prisms arm, 93% in the visual search arm and 34.5% in the standard care arm). The majority of deviations (n=41, 56.2%) related to lack of compliance in the intervention arms (eg prism not worn a minimum of 2 hours daily for 6 weeks or visual exercises not carried out for 30 minutes daily for 6 weeks). Compliance level was similar across the intervention arms. Patients in the Fresnel prisms arm wore the prisms during 27 days on average, and patients in the visual search training arm followed the visual search exercises 28 days on average.
The protocol deviations in the standard group (n=10) were all related to timing and attendance at follow-up visits.
Eighteen patients (69.2%) in the Fresnel prisms arm experienced a total of 42 adverse events of which 28 were classified as headache (Table 7) . Two patients (6.7%) in the visual search training arm expe- hemianopias also report no significant change to extent of visual field loss.
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Published evidence relating to the effectiveness of interventions for post-stroke visual field loss is limited. Pollock and colleagues Evaluation of recruitment and consent has been conducted for this trial and published previously. 23 We experienced greater recovery for hemianopia than previously reported in the literature and this should be taken into consideration when planning future trials with options to increase number of participating recruitment centres.
Adverse events reported with Fresnel prisms therapy included headaches, difficulties with navigation, double vision, optical glare/ aberrations and visual confusion, similar to events reported in previous trials. 14, 24 Headaches were the most common adverse event for Fresnel prisms. We acknowledge that headaches can also be a post-stroke symptom. However, in this trial, given that headaches
were not a symptom reported by patients receiving standard care
and uncommon in those receiving visual search training, they were attributed to the Fresnel prisms treatment. Given the extent and range of adverse events reported with prism wear, caution must be exercised if prescribing prism glasses as an intervention for homonymous hemianopia.
Adverse events for visual search training were minimal and consisted of fatigue and headache. To help minimize these potential side effects, training periods should be curtailed to shorter accumulated periods rather than one long training session.
We used treatment diaries to capture patient use of interventions and extracted data from these and the case report forms as to whether from dependent on whether a health-related or condition-specific questionnaire is required.
| Considerations
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With regard to generalizability, as this is a pilot trial, results should be interpreted with caution. 26 Although we found a statistically significant improvement in VFQ25 for visual search training, our trial was not powered for this. Nonetheless, the clinical differences are encouraging and warrant further investigation.
There remains insufficient evidence to reach conclusions about whether prisms are an effective intervention, and this study provides evidence of a high rate of adverse events associated with prism use.
Clinicians with expert knowledge relating to prisms may consider their use for individual patients, but clinicians and patients both should be fully aware of potential adverse events and have a clear understanding relating to prism use.
| CONCLUSIONS
Our visual search training or Fresnel prisms interventions for hemianopia produced minimal change in visual field area over the 26-week follow-up period. Visual search training produced a significant improvement in vision-related quality of life but not for other activity of daily living tasks. There were no significant improvements for any quality-of-life measure in our Fresnel prisms arm. For the visual search arm, our participants reported a low percentage of adverse events, many continued with training and we found a significant change in quality of life. This must be interpreted with caution given our low sample size.
There are a number of considerations in relation to planning future trials. Assessing change in visual field required formal visual field assessment using a variety of perimeter types. It would help to limit assessment to one method or alternatively remove this as an outcome measure. We experienced low recruitment initially but took measures to improve this with increased number of recruitment centres and met the revised target for recruitment.
T A B L E 7 Outcome measure of adverse events reported for each group 
